The Polyplastics Group will showcase its expanded portfolio of acetal materials for the medical and healthcare market at the Medical Design and Manufacturing (MD&M) West show (Booth #3558) April 12-14 in Anaheim, Calif. The company will highlight its latest offering – the DURACON POM (polyoxymethylene or polyacetal) PM series - for drug contact and delivery applications.
The DURACON PM series complements the company’s TOPAS COC (cyclic olefin copolymer) product, a material for a range of medical applications.
The newest offering in the DURACON PM line is a high-flow grade, DURACON PM27S01N, which offers reduced wall thickness, miniaturization, and lower weight for various medical devices. The PM series also includes DURACON PM09S01N, a standard viscosity grade.
The DURACON PM series exhibits a minimal level of extraction with food simulant (alcohol, acid, etc.) compared to competitive POM grades. The series meets regulatory compliance requirements including ISO10993 and USP Class VI biocompatibility/cytotoxicity, FDA Drug Master File (DMF) and Device Master File (MAF), and EU 10/2011 and FDA food-contact 21 CFR 177.2470.
DURACON POM’s slip and wear properties permit lower friction and thus greater design freedom. The materials also show superior heat and moisture durability compared to competitive medical grades. The DURACON PM series is usable under hot steam and Ethylene Oxide (EtO) sterilization conditions. The materials adhere to strict quality management systems including conformity to the VDI 2017 medical-grade plastics guideline. They also provide full traceability of processes and products, and production management based on GMP principles. Polyplastics also provides uniform quality and global supply.